IDG Leads in Vaccines Development
04 Jul 2024
US$ 19.00
IDG Capital has led in the over Rmb300 million (US$41.3 million) series C+ funding round of Chengdu Maxvax ......
Related Publications
Listen to Japan/South Korea People on the Move (Subscribers' Weekly 04 Oct 2024)...
Subscribers’ Weekly for the week ending: 4th Oct 2024...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.